Form 4 for FTH Faeth Therapeutics, Inc.
Accepted 2025-02-26 00:00:00 ET · period of report 2025-02-19 · accession 0001415889-25-005728 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-26 | 2025-02-19 | FTH | Celebi John | Pres AND CEO, Dir | F - Tax | $0.48 | -5,558 | 105.9K | -5% | -$2,668 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-19 | F | D | 5,558 | $0.48 | 105,862 | D | — | — | (F2) Includes an aggregate of 6,000 shares purchased by the Reporting Person since May 16, 2024 pursuant to the Issuer's 2021 Employee Stock Purchase Plan. |